Coinfection  >>  Pegasys (pegylated interferon α -2a)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pegasys (pegylated interferon α -2a) / Roche
NCT00353418 / 2005-005506-23: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

Completed
4
415
US
Peginterferon alfa-2a, Pegasys, Ribavirin, Copegus
Hoffmann-La Roche
Hepatitis C, Chronic
04/09
04/09
HIVCOBOC-RGT, NCT01925183 / 2012-005591-33: Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C

Checkmark AASLD 2014: HIVCOBOC-RGT
Oct 2014 - Oct 2014: AASLD 2014: HIVCOBOC-RGT
Checkmark HIVCOBOC-RGT
Sep 2014 - Sep 2014: HIVCOBOC-RGT
Completed
4
6
Europe
Pegylated interferon alpha-2a, Pegasys®, Roche, Ribavirin, Copegus®, Roche, Boceprevir, Victrelis®, MSD
Markus Peck-Radosavljevic, Medical University of Vienna
Hepatitis C, Chronic, HIV
06/15
06/15

Download Options